Tag Archives: Clinical Research

COVID-19 CLINICAL EVIDENCE DOWNTIME: HOW TO MAKE USE OF IT!

To date numerous guidances, blogposts, webinars have been published addressing what one must and cannot do in the process of clinical evidence collection due to the COVID-19 pandemic (for overviews see here and here), and with this post I have … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | 1 Comment

CORONAVIRUS AND CLINICAL STUDIES: WHAT TO DO?

By now the Coronvirus outbreak is affecting everyday life worldwide (see latest statistics Johns Hopkins University), and to avoid patient exposure or to reduce the burden on clinical services it also started impacting clinical trials; their execution, monitoring, and publications. … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | 3 Comments

2020 – THE 11th HOUR FOR THE MDR, ISO 14155, & OTHER EU CLINICAL MATTERS

  Nothing could have been more illustrative for the medical device clinical trial environment in Europe  than the storms Ciara and Dennis in February. With BREXIT as a kick off, the Coronavirus spreading around te globe, the MDR deadline less … Continue reading

Posted in Uncategorized | Tagged , , , , , , | 2 Comments

A NEW VERSION OF ISO 14155: WHAT TO EXPECT?

The MDR as well as the current version of MEDDEV 2.7/1 reference ISO 14155 as GCP standard for medical device clinical investigations. Indeed, the 2011 version, but the third edition is in the making, so it can be good to … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | 6 Comments

GDPR: DOES IT IMPACT YOUR CLINICAL STUDY?

It is hard to miss, but as of May 25, 2018, the GDPR becomes effective. Although collection and review of personal data and clinical studies have gone hand-in-hand for decades and therefore I do not expect major changes, the devil … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | 3 Comments

DUTCH HEALTH INSPECTION – THE 4 KNOWS OF THE CONFERENCE ON CLINICAL TRIALS WITH MEDICAL DEVICES

The Dutch Health Inspection (IGZ) organized an invitational conference on clinical research with medical devices end of last year. Representatives of the different stakeholders, such as manufacturers, competent authorities, Ethics Committee’s, and health care providers were present during this conference … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , | Leave a comment

INFORMED CONSENT – 5 CRITICAL ELEMENTS TO MONITOR

Ensuring proper informed consent in clinical studies is a critical process, that protects the rights, safety, and welfare of human subjects involved. It will require even more attention under the new GDPR and with the globalization of clinical trials. Although … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , | 3 Comments

EU MEDICAL DEVICE CLINICAL EVIDENCE 2016/2017

The year 2016 has been a very interesting one from clinical perspective with many developments in the EU medical device regulatory environment, and I am sure we are facing an even more interesting one coming up: The latest draft of … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

EU MEDICAL DEVICE DIRECTIVE REVISION CONTINUED

Last week Glenis Willmott was announced to be the new rapporteur for the Medical Device Directive revision. For me that raised the question what effect this will have on the clinical research aspects of the proposed Medical Device Regulation. Given … Continue reading

Posted in Uncategorized | Tagged , , , , , | 1 Comment

CLINICAL EVIDENCE DILEMMAS: IS MY CLINICAL STUDY POPULATION THE RIGHT ONE?

Is my study population the right one, or in other words: Does my clinical study population represent the patients the study product is meant for? An essential question to answer when designing a clinical study to collect clinical evidence regarding product … Continue reading

Posted in Uncategorized | Tagged , , , , , , | Leave a comment